semaglutide or tirzepatide less side effects vs. Semaglutide: What You Should Know π Semaglutide vs. Tirzepatide β
Description
Careful attention to dietary intake can mitigate this risk
The Ultra-High Efficacy Seeker: Patients needing the absolute maximum weight reduction to meet surgical qualification criteria or to reverse severe comorbidities
Those who switched to placebo at week 36 regained weight, ending at just 9.9 percent total reduction

Results showed a significant reduction in Body Mass Index (BMI) over 24 months, with mean differences of 0.36, 1.08, 1.18, and 1.42 at 3, 6, 12, and 24 months, respectively, with 95% CI, and low heterogeneity ( I = 0.0%)
The clinical trials for tirzepatide reported that GI side effects were the primary reason patients discontinued treatment, and those rates increased at higher doses
